AKCEA THERAPEUTICS INC's ticker is AKCA and the CUSIP is 00972L107. A total of 86 filers reported holding AKCEA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $470,000 | -80.1% | 25,890 | -85.0% | 0.00% | -100.0% |
| Q2 2020 | $2,363,000 | +32.8% | 172,501 | +38.7% | 0.00% | 0.0% |
| Q1 2020 | $1,779,000 | -65.4% | 124,392 | -59.0% | 0.00% | -50.0% |
| Q4 2019 | $5,142,000 | +194.5% | 303,564 | +167.6% | 0.00% | – |
| Q3 2019 | $1,746,000 | -90.0% | 113,452 | -84.7% | 0.00% | -100.0% |
| Q2 2019 | $17,430,000 | -14.3% | 743,294 | +3.5% | 0.01% | -10.0% |
| Q1 2019 | $20,344,000 | +108.0% | 718,089 | +121.2% | 0.01% | +100.0% |
| Q4 2018 | $9,782,000 | +20.1% | 324,567 | +39.5% | 0.01% | +25.0% |
| Q3 2018 | $8,147,000 | +529.6% | 232,644 | +326.2% | 0.00% | – |
| Q2 2018 | $1,294,000 | +145.1% | 54,583 | +165.0% | 0.00% | – |
| Q1 2018 | $528,000 | – | 20,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iguana Healthcare Management, LLC | 100,000 | $1,736,000 | 1.13% |
| BB BIOTECH AG | 1,248,650 | $21,677,000 | 0.61% |
| Virtus ETF Advisers LLC | 18,071 | $314,000 | 0.39% |
| Eventide Asset Management | 420,000 | $7,291,000 | 0.38% |
| Granahan Investment Management | 194,376 | $3,374,000 | 0.26% |
| ALTRINSIC GLOBAL ADVISORS LLC | 150,000 | $2,604,000 | 0.10% |
| Candriam S.C.A. | 114,571 | $1,990,000 | 0.03% |
| ARDSLEY ADVISORY PARTNERS LP | 15,000 | $260,000 | 0.03% |
| Delpha Capital Management, LLC | 1,521 | $26,000 | 0.03% |
| FMR LLC | 9,981,244 | $173,274,000 | 0.02% |